Breast Cancer Cure Drug Pharma Raw Materials Gemcitabine CAS 95058-81-4

Basic Information
Place of Origin: China
Brand Name: Senwayer Brand
Certification: ISO, 9001, USP
Model Number: 95058-81-4
Minimum Order Quantity: 10grams
Price: Discount is possible if your order is big enough
Packaging Details: 10g, 20g, 50g , 100g, 500g. 1kg, 10kg
Delivery Time: within 2 working days
Payment Terms: T/T in advance, Money Gram, Western Union, Bank Transfer.
Supply Ability: 1000kg/month
Detail Information
CAS: 95058-81-4 Apparence: White Crystalline Powder
Purity: 99% Usage: Antimetabolites Anticancer Drugs
MF: C9H11F2N3O4 MW: 263.2
EINECS: 619-100-6
High Light:

antineoplastic drugs


breast cancer drugs

Product Description

Pharma Raw Materials Gemcitabine CAS 95058-81-4 Breast Cancer Ovarian Cure Drugs


Quick detail

CAS No.: 95058-81-4



4-amino-1-[3,3-difluoro-4-hydroxy-5- (hydroxymethyl) tetrahydrofuran-2-yl]- 1H-pyrimidin- 2-one; 3-DEOXY-2,2-DIFLUORO-D-RIBOFURANOSE-3,5-DIBENZOATE

GEMCITABINE HCL; 2'-DEOXY-2',2'-DIFLUOROCYTIDINE; 1-(2-deoxy-2,2-difluoro-β-D-erythropentofuranosyl)cytosine; CYTIDINE, 2'-DEOXY-2',2'-DIFLUORO;

Formula: C9H11F2N3O4
Exact Mass: 263.07200
Molecular Weight: 263.19800
PSA: 110.60000
LogP: -0.70740


Gemcitabine Description:

Gemcitabine, sold under the brand name Gemzar among others,[1] is a chemotherapy medication used to treat a number of types ofcancer. This includes breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer. It is given by slow injection into a vein


Gemcitabine Usage

Ovarian Cancer Gemcitabine in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.
Breast Cancer Gemcitabine in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.
Non-Small Cell Lung Cancer Gemcitabine is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer.
Pancreatic Cancer
Gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with 5-FU.


Recommended Dose and Schedule

The recommended dose of Gemcitabine is 1,000 mg/m2 as an intravenous infusion over 30 minutes on Days 1 and 8 of each 21-day cycle, in combination with carboplatin AUC 4 intravenously after Gemcitabine administration on Day 1 of each 21-day cycle. Refer to carboplatin prescribing information for additional information.


How Gemcitabine Is Given

Gemcitabine is given by infusion through a vein (intravenously, by IV).
There is no pill form of Gemcitabine.
The amount of Gemcitabine you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have. Your doctor will determine your exact dosage and schedule.


Breast Cancer Cure Drug Pharma Raw Materials Gemcitabine CAS 95058-81-4 0

Contact Details
Abby Xiang

Phone Number : +8617764031156

WhatsApp : +8617764031156